GlassScriptPhysician profile
Michael Charles Bounds
NPI 1568755825
$6,266.03
in general payments reported to CMS, 2019-2025
39 companies · $719 in 2025
The $719 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $871 · 2021: $476 · 2022: $1,174 · 2023: $1,166 · 2024: $1,860 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,548 · Travel and Lodging: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.75 |
| Travel and Lodging | $1,197.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,425.37 | 2021-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Silk Road Medical, INC. | $1,019.06 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $847.10 | 2021-2025 | Endurant Iis, Signia, Abre |
| Janssen Pharmaceuticals, INC | $351.94 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $211.01 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $138.73 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Endologix LLC | $133.60 | 2025 | Afx2 Bifurcated Endograft System |
| Baxter Healthcare | $92.18 | 2023-2025 | Floseal, Preveleak |
| Ethicon US, LLC | $82.75 | 2022-2025 | Prolene, Evarrest, Ethicon |
| Tactile Systems Technology INC | $70.26 | 2024 | Entre Plus, Flexitouch Plus |
| Cardiovascular Systems INC. | $60.24 | 2021-2022 | |
| Organogenesis INC. | $56.40 | 2025 | Affinity, Cygnus Dual, Puraply Wound Matrix |
| Takeda Pharmaceuticals U.S.A., INC. | $54.55 | 2021-2022 | |
| Angiodynamics, INC. | $54.02 | 2021-2022 | |
| Stryker Corporation | $46.75 | 2023 | Spy-Phi System |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $45.38 | 2023-2024 | Pico 7, Renasys Go V2 Home, Renasys Touch |
| Philips North America LLC | $44.13 | 2021-2023 | |
| Solventum Corporation | $38.47 | 2024-2025 | Prevena, 3m Coban, Kerramax Care |
| Elutia, INC. | $38.34 | 2021-2022 | |
| Surmodics, INC. | $36.73 | 2022-2023 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Shape Memory Medical INC. | $34.83 | 2025 | Impede Embolization Plug |
| Bolton Medical INC | $34.77 | 2021-2022 | |
| Teleflex LLC | $33.78 | 2022 | |
| Kci USA, INC. | $29.20 | 2022-2023 | Prevena |
| Boston Scientific Corporation | $26.58 | 2022 | |
| Davol INC. | $26.37 | 2024 | Phasix Mesh |
| Convatec INC. | $25.05 | 2025 | |
| Integra Lifesciences Corporation | $24.42 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Glaxosmithkline, LLC. | $21.96 | 2025 | Blenrep |
| Springworks Therapeutics, INC. | $19.60 | 2025 | Ogsiveo |
| Vertex Pharmaceuticals Incorporated | $19.56 | 2024 | |
| Abbott Laboratories | $18.51 | 2024 | Xact |
| Pfizer INC. | $16.38 | 2025 | |
| Eagle Pharmaceuticals, INC. | $16.16 | 2023 | |
| Cvrx, INC. | $15.93 | 2025 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $15.70 | 2023 | Seglentis |
| Lemaitre Vascular, INC. | $13.88 | 2022 | |
| Terumo Medical Corporation | $13.43 | 2024 | Azur Cx Detachable, Angio-Seal, Glidesheath Slender |
| Bioventus LLC | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bounds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.